Pathologic Complete Response and Individual Patient Prognosis After Neoadjuvant Chemotherapy Plus Anti-Human Epidermal Growth Factor Receptor 2 Therapy of Human Epidermal Growth Factor Receptor 2-Positive Early Breast Cancer

  1. van Mackelenbergh, M.T.
  2. Loibl, S.
  3. Untch, M.
  4. Buyse, M.
  5. Geyer, C.E.
  6. Gianni, L.
  7. Schneeweiss, A.
  8. Conte, P.
  9. Piccart, M.
  10. Bonnefoi, H.
  11. Jackisch, C.
  12. Nekljudova, V.
  13. Tang, G.
  14. Valagussa, P.
  15. Neate, C.
  16. Gelber, R.
  17. Poncet, C.
  18. Squifflet, P.
  19. Saad, E.D.
  20. Heinzmann, D.
  21. Denkert, C.
  22. Rastogi, P.
  23. Cortes, J.
  24. Guarneri, V.
  25. de Azambuja, E.
  26. Cameron, D.
  27. Ismael, G.
  28. Wolmark, N.
  29. Cortazar, P.
  30. Montrer des auteurs +
Revue:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology

ISSN: 1527-7755

Année de publication: 2023

Volumen: 41

Número: 16

Pages: 2998-3008

Type: Article

DOI: 10.1200/JCO.22.02241 GOOGLE SCHOLAR